ArticleIranian journal of neurology2018

Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis.

Amir Hashemi-Meshkini et al.PubMed ↗Full text ↗

No numbers read from the abstract.